Prognostic impact of the MDM2/HMGA2 ratio and clinicopathological factors in well-differentiated and dedifferentiated liposarcoma

被引：0
|
作者：
Yamashita, Kyoko [1 ]
Kohashi, Kenichi [2 ]
Yamada, Yuichi [2 ]
Akatsuka, Shinya [3 ]
Oda, Yoshinao
机构：
[1] Japanese Fdn Canc Res, Inst Canc, Koto Ku, Tokyo, Japan
[2] Kyushu Univ, Fukuoka, Fukuoka, Japan
[3] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
95
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic impact of the MDM2/HMGA2 ratio and clinicopathological factors in well-differentiated and dedifferentiated liposarcoma
    Yamashita, Kyoko
    Kohashi, Kenichi
    Yamada, Yuichi
    Akatsuka, Shinya
    Oda, Yoshinao
    MODERN PATHOLOGY, 2019, 32
  • [2] Prognostic significance of the MDM2/HMGA2 ratio and histological tumor grade in dedifferentiated liposarcoma
    Yamashita, Kyoko
    Kohashi, Kenichi
    Yamada, Yuichi
    Akatsuka, Shinya
    Ikuta, Kunihiro
    Nishida, Yoshihiro
    Toyokuni, Shinya
    Oda, Yoshinao
    GENES CHROMOSOMES & CANCER, 2021, 60 (01): : 26 - 37
  • [3] MDM2 Copy Numbers in Well-Differentiated and Dedifferentiated Liposarcoma
    Ware, Patrick L.
    Snow, Anthony N.
    Gvalani, Maya
    Pettenati, Mark J.
    Qasem, Shadi A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (03) : 334 - 341
  • [4] A novel HMGA2::KITLG fusion in a dedifferentiated liposarcoma with amplification of MDM2 and HMGA2
    Zhou, Shishan
    Zhang, Changliang
    Zhang, Zhipeng
    Hu, Yongbin
    Zhao, Lina
    Hu, Wentao
    Chen, Si
    Li, Bin
    Xiao, Sheng
    GENES CHROMOSOMES & CANCER, 2024, 63 (01):
  • [5] HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon
    Italiano, Antoine
    Bianchini, Laurence
    Keslair, Frederique
    Bonnafous, Stephanie
    Cardot-Leccia, Nathalie
    Coindre, Jean-Michel
    Dumollard, Jean-Marc
    Hofman, Paul
    Leroux, Agnes
    Mainguene, Claire
    Peyrottes, Isabelle
    Ranchere-Vince, Dominique
    Terrier, Philippe
    Tran, Albert
    Gual, Philippe
    Pedeutour, Florence
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (10) : 2233 - 2241
  • [6] Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas
    Saada-Bouzid, Esma
    Burel-Vandenbos, Fanny
    Ranchere-Vince, Dominique
    Birtwisle-Peyrottes, Isabelle
    Chetaille, Bruno
    Bouvier, Corinne
    Chateau, Marie-Christine
    Peoc'h, Michel
    Battistella, Maxime
    Bazin, Audrey
    Gal, Jocelyn
    Michiels, Jean-Francois
    Coindre, Jean-Michel
    Pedeutour, Florence
    Bianchini, Laurence
    MODERN PATHOLOGY, 2015, 28 (11) : 1404 - 1414
  • [7] Prognostic relevance of myogenic differentiation, FNCLCC grading and MDM2 amplification levels in well-differentiated and dedifferentiated liposarcoma: A study of 70 cases
    Lecoutere, E.
    Van Dorpe, J.
    Verbeke, S.
    van Gorp, J.
    Flucke, U.
    Van Bockstal, M.
    Ferdinande, L.
    Creytens, D.
    VIRCHOWS ARCHIV, 2016, 469 : S215 - S215
  • [8] Tumour histology and primary site but not MDM2 amplification levels are prognostic for clinical outcomes in well differentiated and dedifferentiated liposarcoma
    Chew, W. H. W.
    Chan, J. Y.
    Goh, W. L.
    Lim, J. H. C.
    Tan, S. H.
    Somasundaram, N.
    Poon, E. Y. L.
    Lim, A. S. T.
    Tan, M. H.
    Soo, K. C.
    Teo, M.
    Tay, T. K. Y.
    Selvarajan, S.
    Sittampalam, K.
    Quek, R.
    ANNALS OF ONCOLOGY, 2017, 28 : 150 - 150
  • [9] IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma
    Klingbeil, Kyle D.
    Tang, Jack Pengfei
    Graham, Danielle S.
    Lofftus, Serena Y.
    Jaiswal, Amit Kumar
    Lin, Tasha L.
    Frias, Chris
    Chen, Lucia Y.
    Nakasaki, Manando
    Dry, Sarah M.
    Crompton, Joseph G.
    Eilber, Fritz C.
    Rao, Dinesh S.
    Kalbasi, Anusha
    Kadera, Brian E.
    CANCERS, 2023, 15 (18)
  • [10] MDM2-p53 Pathway Status in Clinical Samples of Well-Differentiated and Dedifferentiated Liposarcoma
    Kumagai, A.
    Motoi, T.
    Yoshida, A.
    Imamura, T.
    Fukusato, T.
    LABORATORY INVESTIGATION, 2011, 91 : 17A - 17A
12345